IOP Changes Associated With SICS and Phako
Primary Purpose
Cataract, Glaucoma
Status
Completed
Phase
Early Phase 1
Locations
Study Type
Interventional
Intervention
cataract surgery
Sponsored by
About this trial
This is an interventional diagnostic trial for Cataract
Eligibility Criteria
Inclusion Criteria:Age over 40 requiring cataract surgery -
Exclusion Criteria: inability to follow up, lens not suitable for phacoemulsification, prior intraocular surgery, glaucoma
-
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
phako
MSICS
Arm Description
eyes receiving phakoemulsification for cataract surgery
Eyes undergoing manual small incision cataract surgery
Outcomes
Primary Outcome Measures
Intraocular pressure lowering
intraocular pressure measured with aplanation tonometry
Secondary Outcome Measures
Angle anatomy
OCT changes in angle anatomy
Full Information
NCT ID
NCT02642211
First Posted
December 19, 2015
Last Updated
January 5, 2016
Sponsor
Robin, Alan L., M.D.
1. Study Identification
Unique Protocol Identification Number
NCT02642211
Brief Title
IOP Changes Associated With SICS and Phako
Official Title
An Evaluation of Intraocular Pressure Reduction Following Phacoemulsification and Manual Small Incision Cataract Surgery: A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2015
Overall Recruitment Status
Completed
Study Start Date
January 2014 (undefined)
Primary Completion Date
September 2015 (Actual)
Study Completion Date
September 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Robin, Alan L., M.D.
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Prospective randomized trial in patients requiring cataract surgery in which IOP, angle anatomy and other demographic and clinical data are compared. Subjects randomized to both MSICS and phakoemulsification
Detailed Description
Prospective, randomized, double masked, parallel assignment clincal trial. Five hundred eyes of 500 participants between 40 - 70 years with normal IOP, gonioscopically open angles and age related cataract. Eyes underwent phacoemulsification or MSICS following a 1:1 randomization and allocation code. Best corrected vision (BCVA), IOP, comprehensive slit lamp evaluation and anterior segment optical coherence tomography (ASOCT) were performed at baseline and at 1, 3 and 6 months follow up.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract, Glaucoma
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Early Phase 1
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
500 (Actual)
8. Arms, Groups, and Interventions
Arm Title
phako
Arm Type
Active Comparator
Arm Description
eyes receiving phakoemulsification for cataract surgery
Arm Title
MSICS
Arm Type
Active Comparator
Arm Description
Eyes undergoing manual small incision cataract surgery
Intervention Type
Procedure
Intervention Name(s)
cataract surgery
Intervention Description
Eyes (one eye per patient) randomized to either phacoemulsification and intraocular lens insertion or small incision cataract surgery and intraocular lens insertion
Primary Outcome Measure Information:
Title
Intraocular pressure lowering
Description
intraocular pressure measured with aplanation tonometry
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Angle anatomy
Description
OCT changes in angle anatomy
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:Age over 40 requiring cataract surgery -
Exclusion Criteria: inability to follow up, lens not suitable for phacoemulsification, prior intraocular surgery, glaucoma
-
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
plan to share in paper form and at national meetings
Learn more about this trial
IOP Changes Associated With SICS and Phako
We'll reach out to this number within 24 hrs